HUMBLE
Hamilton Uveal Melanoma Brachytherapy Long-term Estimator
An AI-Driven Prognostic Tool from the Hamilton Eye Institute
Predicted Survival
These results are probabilistic and should be interpreted in the context of clinical care.
This patient is categorized as High Risk.
Overall Survival
Compare the patient's curve to the broader patient population.
Mortality Cumulative Incidence
This chart shows cumulative probabilities of remaining alive, passing away from cancer-related causes, or passing away from other causes over a 10-year period.
Patient-Specific SHAP Analysis
SHAP Waterfall Plot
Explains how each feature contributed to the predicted probability.
Survival Probabilities
1 Year, 5 Years, and 10 YearsSurvival Endpoint | 1 Year | 5 Years | 10 Years |
---|---|---|---|
Overall | 96.12% | 20.2% | 8.79% |
Recurrence-Free | 98.43% | 81.59% | 77.67% |
Enucleation-Free | 93.81% | 78.08% | 65.44% |
Metrics Summary
C-index and Integrated Brier Score (IBS)Survival Model | C-index | IBS (5 years) | IBS (10 years) |
---|---|---|---|
Overall Survival | 0.813 | 0.049 | 0.091 |
Recurrence-Free | 0.701 | 0.044 | 0.097 |
Enucleation-Free | 0.768 | 0.062 | 0.107 |